Abstract
The objective of this systematic review was to assess the effectiveness of shark cartilage as a treatment option for cancer patients. Six databases were searched from their inception to August 2010. Only RCTs testing shark cartilage against any control intervention in humans with any type of cancer were considered. The selection of studies, data extraction and validation were performed by one reviewer. For safety and toxicity studies, uncontrolled trials and case studies were excluded. Two RCTs met the inclusion criteria. The methodological quality of studies was high. None of the RCTs suggested that shark cartilage plus conventional treatment lead to a significant reduction in tumour size or improvements in overall survival when compared to placebo and conventional treatment. Current clinical evidence does not support the efficacy of oral shark cartilage in cancer treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
